In vivo CEST MR imaging of U87 mice brain tumor angiogenesis using targeted LipoCEST contrast agent at 7 T.
about
Targeted nanotechnology for cancer imaging.Variable delay multi-pulse train for fast chemical exchange saturation transfer and relayed-nuclear overhauser enhancement MRI.Nanoprobes visualizing gliomas by crossing the blood brain tumor barrier.Diamagnetic chemical exchange saturation transfer (diaCEST) liposomes: physicochemical properties and imaging applicationsEntrapment of a neutral Tm(III)-based complex with two inner-sphere coordinated water molecules into PEG-stabilized vesicles: towards an alternative strategy to develop high-performance LipoCEST contrast agents for MR imaging.Characterization of a lanthanide complex encapsulated with MRI contrast agents into liposomes for biosensor imaging of redundant deviation in shifts (BIRDS).A review of optimization and quantification techniques for chemical exchange saturation transfer MRI toward sensitive in vivo imaging.LipoCEST and cellCEST imaging agents: opportunities and challenges.Cellular and Molecular Imaging Using Chemical Exchange Saturation Transfer.A microfluidic platform for quantitative analysis of cancer angiogenesis and intravasationNuts and bolts of chemical exchange saturation transfer MRI.Nanoparticle-based chemical exchange saturation transfer (CEST) agents.Assessment of lymphatic impairment and interstitial protein accumulation in patients with breast cancer treatment-related lymphedema using CEST MRIDetection of in vivo enzyme activity with CatalyCEST MRI.Tumor targeting and imaging with dual-peptide conjugated multifunctional liposomal nanoparticles.A diaCEST MRI approach for monitoring liposomal accumulation in tumorsMulti-echo length and offset VARied saturation (MeLOVARS) method for improved CEST imaging.Vascular targeting of nanoparticles for molecular imaging of diseased endothelium.Design and testing of paramagnetic liposome-based CEST agents for MRI visualization of payload release on pH-induced and ultrasound stimulation.
P2860
Q27010317-D4ED92C0-BB3A-4773-97C2-417B0AB1135DQ30652440-BA4AA41D-21B8-4370-907D-52A8D8430858Q30672749-C6E99903-CEC5-4632-9320-7FD28877DAC0Q30715520-01D75C8B-8E28-4802-AAB3-50E36765CD6EQ30807730-6AE52205-F562-4BB6-8601-94957351B232Q30859122-8D375051-DA74-4827-9F48-3539F260054BQ30887000-C571AD4B-0913-43A5-AED7-CC0917DE2A9DQ31039858-8E8FAB9A-A438-4B16-8E9B-658449E3711BQ31137184-51EE14D8-D3FF-4C2E-90C8-A5B63B9F7164Q34305984-7DDC72D4-E6FA-4E21-8DBC-4D5BC1704730Q34543331-319F5E36-34AA-454B-A9CC-ED9FD820017EQ34778402-E8C1B54E-A453-4609-80F1-7188317995D5Q36032907-24464173-F1C6-44F4-87F0-2CAB765C2E21Q37093095-FEE61F2F-431B-4E95-A338-3B49B90E9EFDQ37390746-B5403BCA-3FB8-4BCF-85F3-B074F8AD2F47Q37725101-248AD20C-F30E-47FC-AC02-23E9818AAC5EQ38927828-2ADBB816-BBAD-4DD9-AAA8-59383A1B4237Q38957484-DEE727D9-CCA6-40CD-97D6-5923486564B9Q39350171-BBCB28F8-E3B6-4507-AB8A-787F034C862B
P2860
In vivo CEST MR imaging of U87 mice brain tumor angiogenesis using targeted LipoCEST contrast agent at 7 T.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
In vivo CEST MR imaging of U87 ...... ipoCEST contrast agent at 7 T.
@en
In vivo CEST MR imaging of U87 ...... ipoCEST contrast agent at 7 T.
@nl
type
label
In vivo CEST MR imaging of U87 ...... ipoCEST contrast agent at 7 T.
@en
In vivo CEST MR imaging of U87 ...... ipoCEST contrast agent at 7 T.
@nl
prefLabel
In vivo CEST MR imaging of U87 ...... ipoCEST contrast agent at 7 T.
@en
In vivo CEST MR imaging of U87 ...... ipoCEST contrast agent at 7 T.
@nl
P2093
P2860
P50
P356
P1476
In vivo CEST MR imaging of U87 ...... ipoCEST contrast agent at 7 T.
@en
P2093
Caroline Robic
Christelle Medina
Fawzi Boumezbeur
Franck Lethimonnier
Françoise Geffroy
Jean-François Mayer
Julien Flament
Philippe Robert
P2860
P304
P356
10.1002/MRM.24217
P577
2012-02-29T00:00:00Z